Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Change in Cash (2020 - 2021)

Historic Change in Cash for Design Therapeutics (DSGN) over the last 2 years, with Q4 2021 value amounting to -$59.1 million.

  • Design Therapeutics' Change in Cash fell 689325.44% to -$59.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was $296.2 million, marking a year-over-year increase of 1276663.77%. This contributed to the annual value of $1.4 million for FY2024, which is 12571.7% up from last year.
  • Per Design Therapeutics' latest filing, its Change in Cash stood at -$59.1 million for Q4 2021, which was down 689325.44% from -$13.2 million recorded in Q3 2021.
  • In the past 5 years, Design Therapeutics' Change in Cash ranged from a high of $398.3 million in Q1 2021 and a low of -$59.1 million during Q4 2021